These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7266450)

  • 1. Newborn metabolic screening in Minnesota. II. PKU and galactosemia.
    Jenkins MB
    Minn Med; 1981 Jul; 64(7):429-32, 398. PubMed ID: 7266450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening and therapy of 6 metabolic diseases of hereditary nature which are possible causes of mental retardation: screening of 1,900,000 newborn infants since the year 1965].
    Menne F
    Clin Ter; 1979 Mar; 88(5):445-59. PubMed ID: 466967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Newborn infant screening program in Switzerland].
    Gitzelmann R
    Bull Schweiz Akad Med Wiss; 1972 Sep; 28(5):294-301. PubMed ID: 4645587
    [No Abstract]   [Full Text] [Related]  

  • 4. Newborn screening for hereditary metabolic disorders in Manitoba, 1965-1970.
    Fox JG; Hall DL; Haworth JC; Maniar A; Sekla L
    Can Med Assoc J; 1971 Jun; 104(12):1085-8. PubMed ID: 5580751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Texas Newborn Screening Program.
    Therrell BL; Brown LO; Dziuk PE; Peter WP
    Tex Med; 1983 Feb; 79(2):44-6. PubMed ID: 6836536
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal screening for phenylketonuria. II. Age dependence of initial phenylalanine in infants with PKU.
    Holtzman NA; Mellits ED; Kallman CH
    Pediatrics; 1974 Mar; 53(3):353-7. PubMed ID: 4815254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for congenital hypothyroidism, phenylketonuria, galactosemia and biotinidase deficiency in a sample of mentally retarded patients in the city of Havana].
    Marrero-González N; Portuondo-Sao M; Lardoeyt-Ferrer R; Tassé-Vila D; Lantigua-Cruz A
    Rev Neurol; 2003 May 16-31; 36(10):913-6. PubMed ID: 12766862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactosemia identified in newborn screening program; clinical and biochemical characteristics.
    Kelly S
    N Y State J Med; 1980 Nov; 80(12):1836-9. PubMed ID: 6939992
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal hypothyroidism, phenylketonuria and galactosemia screening in metropolitan Shanghai.
    Chen RG; Sun M; Ni YY; Pan XS; Chen JZ; Zhang YF; Liu H; Zhang MH; Xu HZ; Wu YL
    Chin Med J (Engl); 1984 Jan; 97(1):61-5. PubMed ID: 6428834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methods and results of screening newborn infants for aminoacidopathies].
    Bickel H
    Monatsschr Kinderheilkd (1902); 1976 Sep; 129(9):650-3. PubMed ID: 979984
    [No Abstract]   [Full Text] [Related]  

  • 11. PKU and hypothyroidism. Are we missing cases in Kansas?
    Schloesser PT; Hollowell JG; Petty M; Bonam S; Martin HK
    J Kans Med Soc; 1979 Jun; 80(6):343-4. PubMed ID: 458215
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenylketonuria screening in Scotland 1965-1977.
    Stevenson JS; Kennedy R
    Health Bull (Edinb); 1978 Sep; 36(5):227-9. PubMed ID: 701005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neonatal screening of phenylketonuria in France. Statistical data].
    Briard ML
    Arch Fr Pediatr; 1983; 40 Suppl 1():215-7. PubMed ID: 6882138
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening studies in newborn infants].
    Gröbe H
    Monatsschr Kinderheilkd; 1983 Nov; 131(11):806-9. PubMed ID: 6664350
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening for congenital metabolic disorders. Indication and results].
    Bickel H
    Monatsschr Kinderheilkd; 1983 Jun; 131(6):323-7. PubMed ID: 6888386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Screening for hyperphenylalaninemia and hypertyrosinemia in the newborn].
    Dhondt JL; Farriaux JP
    Arch Fr Pediatr; 1977 May; 34(5):474-5. PubMed ID: 889411
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results obtained after 24 months of systematic screening for phenylketonuria].
    Thiriar MJ; Thiriar-de Lancker C; Vis HL
    Acta Paediatr Belg; 1967; 21(6):463-76. PubMed ID: 6083085
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a nation-wide neonatal metabolic screening programme in Sweden 1965-1979.
    Alm J; Larsson A
    Acta Paediatr Scand; 1981 Sep; 70(5):601-7. PubMed ID: 7324907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening: notes added in proof.
    Levy HL
    Adv Hum Genet; 1973; 4():389-94. PubMed ID: 4783333
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Frequency of some metabolic disorders in Poland.
    Bozkowa K; Cabalska MB
    Acta Paediatr Scand; 1974 May; 63(3):443-4. PubMed ID: 4838973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.